Suboptimum use of FDA drug advisory committees

Asa L. Tapley; Peter Lurie; Sidney M. Wolfe

doi:10.1016/S0140-6736(06)69892-9

Suboptimum use of FDA drug advisory committees

Asa L. Tapley, Peter Lurie, Sidney M. Wolfe

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2210
Number of pages	1
Journal	Lancet
Volume	368
Issue number	9554
DOIs	https://doi.org/10.1016/S0140-6736(06)69892-9
State	Published - Dec 23 2006
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1016/S0140-6736(06)69892-9

Cite this

@article{d5d2d45761a947ada01a05ae17aa5804,

title = "Suboptimum use of FDA drug advisory committees",

author = "Tapley, {Asa L.} and Peter Lurie and Wolfe, {Sidney M.}",

year = "2006",

month = dec,

day = "23",

doi = "10.1016/S0140-6736(06)69892-9",

language = "English (US)",

volume = "368",

pages = "2210",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "9554",

}

TY - JOUR

T1 - Suboptimum use of FDA drug advisory committees

AU - Tapley, Asa L.

AU - Lurie, Peter

AU - Wolfe, Sidney M.

PY - 2006/12/23

Y1 - 2006/12/23

UR - http://www.scopus.com/inward/record.url?scp=33845655992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845655992&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(06)69892-9

DO - 10.1016/S0140-6736(06)69892-9

M3 - Letter

C2 - 17189031

AN - SCOPUS:33845655992

SN - 0140-6736

VL - 368

SP - 2210

JO - The Lancet

JF - The Lancet

IS - 9554

ER -

Suboptimum use of FDA drug advisory committees

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this